Why a simple blood test could save your kidneys
Imagine you have heart disease. You take your medicine, watch your diet, and see your doctor regularly. But what if your blood holds a hidden clue about another silent threat—your kidneys?
A new study suggests that four simple inflammatory markers in the blood can predict which heart patients are most likely to develop chronic kidney disease (CKD). One marker, in particular, stands out as the strongest early warning signal.
Chronic kidney disease is a quiet condition. It often has no symptoms until it’s advanced. About 1 in 7 adults in the U.S. has CKD, and many don’t know it.
For people with coronary artery disease (CAD), the risk is even higher. The same inflammation that damages blood vessels in the heart can also harm the kidneys. But doctors don’t always have a simple way to spot kidney risk early in these patients.
This study looked for a better early warning system.
The surprising shift
Doctors already use blood tests to check kidney function, like creatinine or eGFR. But those tests often show damage only after it has started.
What if we could predict risk before the kidneys begin to fail?
Researchers tested four composite inflammatory markers—AISI, SIRI, SII, and PLR. These are calculated from routine blood counts (white cells, platelets, etc.). They’re not new tests, just new ways to read the same data.
But here’s the twist: one of these markers—AISI—stood out as the best predictor.
How the body’s “traffic jam” signals danger
Think of inflammation like a traffic jam in your blood vessels. When immune cells pile up, they can clog small vessels and cause damage over time.
The four markers measure different parts of this “traffic jam.” For example:
- SII looks at platelets and neutrophils (a type of white cell).
- PLR compares platelets to lymphocytes (another white cell).
- AISI combines all key immune cells into one score.
AISI is like a full traffic report—it gives the clearest picture of overall inflammation. That’s why it may be the best early warning sign.
What the study looked at
Researchers studied 5,181 patients with coronary artery disease from three medical centers. They tracked these patients for several years to see who developed chronic kidney disease.
They used standard statistical models to link the four inflammatory markers to kidney risk. They also checked how well each marker predicted future CKD.
All four markers were linked to a higher risk of kidney disease. The higher the level, the greater the risk.
But AISI was the standout.
- Patients with AISI above 115 had a significantly higher risk.
- The same pattern held for the other markers, but AISI consistently performed best.
- In statistical tests, AISI had the highest predictive accuracy.
Translation: A simple blood count, already done in most clinics, could flag kidney risk early.
But there’s a catch
This doesn’t mean this treatment is available yet.
The study shows an association, not a cause. It doesn’t prove that lowering AISI will protect the kidneys. And the marker isn’t part of routine care right now.
What experts say
Researchers say AISI could be a useful tool for early risk stratification. That means sorting patients into risk groups so doctors can act sooner.
But they caution that more studies are needed to confirm these findings and to see if using AISI in practice actually improves outcomes.
If you have coronary artery disease, talk to your doctor about your kidney health. Ask if your blood work includes markers of inflammation.
Right now, AISI is not a standard test. But it’s calculated from a complete blood count (CBC), which is common. Your doctor may be able to look at your numbers and discuss your risk.
This study was observational, so it can’t prove cause and effect. It included patients from three centers, which may not represent all populations. And it only looked at people with CAD, so the results may not apply to everyone.
Next steps include larger, more diverse studies and clinical trials to see if using AISI to guide care actually prevents kidney disease. If confirmed, this simple marker could become part of routine risk assessment for heart patients.
For now, it’s a promising clue—one that could help doctors and patients act earlier to protect the kidneys.